Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children
Public ClinicalTrials.gov record NCT02497716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Single-dose Study Testing Rivaroxaban Granules for Oral Suspension Formulation in Children From 2 Months to 12 Years With Previous Thrombosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To characterize the pharmacokinetic profile of rivaroxaban administered as granules for suspension formulation and to document safety and tolerability
Study identification
- NCT ID
- NCT02497716
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Months to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2015
- Primary completion
- May 21, 2018
- Completion
- May 21, 2018
- Last update posted
- Apr 15, 2019
2015 – 2018
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Children's Hospital Oakland | Oakland | California | 94609 | — |
| Riley Hospital For Children | Indianapolis | Indiana | 46202 | — |
| Carolinas Healthcare System | Charlotte | North Carolina | 28204 | — |
| Nationwide Children's Hospital | Columbus | Ohio | 43205-2696 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
Recently updated Thrombosis trials
Other public records listing Thrombosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07613840: Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Recruiting
- NCT07597239: Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization Active, not recruiting
- NCT06820515: ATHNdataset Registry Recruiting
- NCT07137429: Platelet Volunteers, Longitudinal and Multi-omic Study Recruiting
- NCT07498517: Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT Not yet recruiting
- NCT06676904: Neonatal Platelet Transfusion Threshold Trial Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02497716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2019 · Synced Sep 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02497716 live on ClinicalTrials.gov.